65,437 trials
Infections, Papillomavirus
Primary: Number of Subjects With Histopathologically-confirmed Cervical Intraepithelial Neoplasia (CIN)2+ Associated With HPV-16 and/or -18 Cervical Infection in Subjects HPV DNA…
Menorrhagia · Heavy Menstrual Bleeding
Primary: Number of Subjects With at Least One Adverse Event During the Study — 678 participants
Healthy · Therapeutic Equivalency
Primary: Maximum Plasma Concentration (Cmax) for Zolpidem Tartrate — 123.61; 131.92 ng/mL
Attention Deficit Hyperactivity Disorder · Oppositional Defiant Disorder
Primary: Change From Baseline to 8 Week Endpoint in Swanson, Nolan and Pelham Questionnaire (SNAP-IV): Attention-Deficit/Hyperactivity Disorder (ADHD) Subscale — 42.7; 41.5…
Hepatectomy
Primary: The Effect of Ketamine on Interleukin 6 (IL-6) Synthesis in Hepatic Resections Requiring Temporary Porto-arterial Occlusion (Pringle Maneuver) — 116.14; 151.29 pg/ml…
Intra-Abdominal Hypertension
Primary: Intra-abdominal Pressure(IAP) Measurements in NICU Patients. — 1219 IAP measurements
Congestive Heart Failure · Cardiac Resynchronization Therapy
Primary: Patient Compliance of Weight and Blood Pressure External Monitoring and Home Monitoring Transmissions. Percentage of Days Transmitted. — 71; 71; 83 Percent of days
Early Stage Parkinson's Disease
Primary: Number of Subjects With at Least One Adverse Event During This Open-label Extension Study — 369 Subjects
Hypertension
Primary: Trough Seated Diastolic Blood Pressure (DBP) Control — 504; 160; 19; 84 Participants
Hypercholesterolemia · Dyslipidemia · Coronary Heart Disease
Primary: Number of Patients Attaining NCEP LDL-C Target at Week 16 — 98; 45 particpants
Type II Diabetes Mellitus · Dyslipidemia
Primary: Percent Change From Baseline Low Density Lipoprotein Cholesterol (LDL-C) — -40.78; -43.25 percent change
Hypercholesterolemia · Dyslipidemias
Primary: Change From Baseline in LDL-C — -43.18; -44.26 percent change
Congestive Heart Failure
Primary: Percentage of Subjects Classified as "Not Worsened" for Changes in the Minnesota Living With Heart Failure Questionnaire and Six-minute Walk Distance Between Periods of…
Chronic Plaque Psoriasis
Primary: Percentage of Participants Who Achieve a PASI75 Response at Week 16 Compared With Baseline (Week 0) — 70.9; 64.8 percentage of participants — p=0.086
Hypercholesterolemia · Dyslipidemia
Primary: Percent Change From Baseline in LDL-C — -43.96; -43.77 mg/dL